Amendment Statement of Principles concerning cardiomyopathy (Balance of Probabilities) (No. 54 of 2025)

Administered by Department of Veterans' Affairs

Legislation au F2025L00510 Not in force Legislative Instrument

Legislation content

EXPLANATORY STATEMENT

 

AMENDMENT Statement of Principles concerning

CARDIOMYOPATHY

(BALANCE OF PROBABILITIES) (NO. 54 OF 2025)

 

VETERANS' ENTITLEMENTS ACT 1986

MILITARY REHABILITATION AND COMPENSATION ACT 2004

 

  1.              This is the Explanatory Statement to the Amendment Statement of Principles concerning cardiomyopathy (Balance of Probabilities) (No. 54 of 2025).

Background

  1.              The Repatriation Medical Authority (the Authority) has determined, under subsections 196B(3) and (8) of the Veterans' Entitlements Act 1986 (the VEA), Amendment Statement of Principles concerning cardiomyopathy (Balance of Probabilities) (No. 54 of 2025).
  2.              This Instrument amends Statement of Principles concerning cardiomyopathy (Balance of Probabilities) (No. 58 of 2024) (Federal Register of Legislation No. F2024L00761) by:
  • inserting a new factor in subsection 9(2a) concerning having infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Day of Commencement

  1.              This Instrument also specifies a day of commencement for the amendment in accordance with subsection 12(3) of the Legislation Act 2003.

Consultation

  1.              Prior to determining this Instrument, the Authority advertised its intention to undertake an investigation in relation to Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (COVID-19) as a factor in cardiomyopathy in the Government Notices Gazette of 18 December 2024, and circulated a copy of the notice of intention to investigate to a wide range of organisations representing veterans, service personnel and their dependants.  The Authority invited submissions from the Repatriation Commission, the Military Rehabilitation and Compensation Commission, organisations and persons referred to in section 196E of the VEA, and any person having expertise in the field.  No submissions were received for consideration by the Authority in relation to the investigation.

Human Rights

  1.              This instrument is compatible with the Human Rights and Freedoms recognised or declared in the International Instruments listed in Section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011.  A Statement of Compatibility with Human Rights follows.

Finalisation of Investigation

  1.              The determining of this Instrument finalises the investigation in relation to exposure as a factor in cardiomyopathy as advertised in the Government Notices Gazette of 18 December 2024.

References

  1.              A list of references relating to the above condition is available on the Authority's website at: www.rma.gov.au. Any other document referred to in this Statement of Principles is available on request to the Repatriation Medical Authority at the following address:

              

Email:    info@rma.gov.au

Post:      The Registrar

Repatriation Medical Authority

GPO Box 1014

BRISBANE    QLD    4001

 


Statement of Compatibility with Human Rights

(Prepared in accordance with Part 3 of the Human Rights (Parliamentary Scrutiny) Act 2011)

 

Instrument No.:   Amendment Statement of Principles No. 54 of 2025

Kind of Injury, Disease or Death: cardiomyopathy

 

This Legislative Instrument is compatible with the human rights and freedoms recognised or declared in the international instruments listed in section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011.

Overview of the Legislative Instrument

1. This Legislative Instrument is determined pursuant to subsection 196B(3) of the Veterans' Entitlements Act 1986 (the VEA) for the purposes of the VEA and the Military Rehabilitation and Compensation Act 2004 (the MRCA).  Part XIA of the VEA requires the determination of these instruments outlining the factors connecting particular kinds of injury, disease or death with service such being determined solely on the available sound medical-scientific evidence.

2. This Legislative Instrument:-

  • facilitates claimants in making, and the Repatriation Commission and the Military Rehabilitation and Compensation Commission in assessing, claims under the VEA and the MRCA respectively, by specifying the circumstances in which medical treatment and compensation can be extended to eligible persons who have cardiomyopathy;
  • facilitates the review of such decisions by the Veterans' Review Board and the Administrative Appeals Tribunal;
  • includes having infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as a new factor which the current sound medical-scientific evidence indicates must exist before it can be said that, on the balance of probabilities, cardiomyopathy is connected with the circumstances of eligible service rendered by a person;
  • amends Instrument No. 58 of 2024; and
  • reflects developments in the available sound medical-scientific evidence concerning cardiomyopathy which have occurred since that earlier instrument was determined. 

3. The Instrument is assessed as being a technical instrument which improves the medico-scientific quality of outcomes under the VEA and the MRCA. 

Human Rights Implications

4. This Legislative Instrument does not derogate from any human rights. It promotes the human rights of veterans, current and former Defence Force members as well as other persons such as their dependents, including:

  • the right to social security (Art 9, International Covenant on Economic, Social and Cultural Rights; Art 26, Convention on the Rights of the Child and Art 28, Convention on the Rights of Persons with Disabilities) by helping to ensure that the qualifying conditions for the benefit are 'reasonable, proportionate and transparent'[1];
  • the right to an adequate standard of living (Art 11, ICESCR; Art 27, CRC and Art 28, CRPD) by facilitating the assessment and determination of social security benefits;
  • the right to the enjoyment of the highest attainable standard of physical and mental health (Art 12, ICESCR and Art 25, CRPD), by facilitating the assessment and determination of compensation and benefits in relation to the treatment and rehabilitation of veterans and Defence Force members;
  • the rights of persons with disabilities by facilitating the determination of claims relating to treatment and rehabilitation (Art 26, CRPD); and
  • ensuring that those rights "will be exercised without discrimination of any kind as to race, colour, sex, language, religion, political or other opinion, national or social origin, property, birth or other status" (Art 2, ICESCR).

Conclusion

This Legislative Instrument is compatible with human rights as it does not derogate from and promotes a number of human rights.

 

Repatriation Medical Authority

 

 

 

 

 

 

[1] In General Comment No. 19 (The right to social security), the Committee on Economic, Social and Cultural Rights said (at paragraph 24) this to be one of the elements of ensuring accessibility to social security.

Overview

The Amendment Statement of Principles concerning cardiomyopathy (Balance of Probabilities) (No. 54 of 2025) was enacted to address the evolving understanding of factors contributing to cardiomyopathy among eligible veterans and service personnel, particularly in relation to infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This legislative instrument was determined by the Repatriation Medical Authority under the Veterans' Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004. The policy objective is to ensure that the criteria for connecting cardiomyopathy with service are based on the most current medical-scientific evidence, thereby facilitating claims and assessments of compensation and medical treatment for affected individuals. This amendment introduces a new factor concerning SARS-CoV-2 infection, reflecting the latest developments in medical-scientific understanding and ensuring that the legislation remains relevant and responsive to new evidence. The legislative instrument is also designed to promote human rights by providing a transparent, reasonable, and proportionate framework for the assessment of claims related to cardiomyopathy.

Scope and Application

The Amendment Statement of Principles concerning cardiomyopathy (Balance of Probabilities) (No. 54 of 2025) applies to veterans and current or former Defence Force members who have cardiomyopathy and are seeking medical treatment or compensation under the Veterans' Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004. The amendment specifically addresses the connection between cardiomyopathy and infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also known as COVID-19. This Instrument amends the existing Statement of Principles concerning cardiomyopathy (Balance of Probabilities) (No. 58 of 2024) by inserting a new factor related to SARS-CoV-2 infection, reflecting recent developments in medical-scientific evidence. The amendment applies nationally, governed by the Commonwealth, and is subject to the sound medical-scientific evidence available. There are no stated exclusions or thresholds in this amendment; however, the instrument may be further extended or restricted through subordinate instruments. This Legislative Instrument is compatible with human rights and promotes the rights of veterans and Defence Force members, ensuring that they receive appropriate medical treatment and compensation without discrimination.

Key Provisions

The Amendment Statement of Principles concerning cardiomyopathy (Balance of Probabilities) (No. 54 of 2025) (the Amendment Instrument) amends the existing Statement of Principles concerning cardiomyopathy (Balance of Probabilities) (No. 58 of 2024) by inserting a new factor concerning infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This change is made under the authority provided by subsections 196B(3) and (8) of the Veterans' Entitlements Act 1986 (VEA). The amendment is designed to improve the accuracy and relevance of the criteria for determining claims related to cardiomyopathy, ensuring they are based on the most current medical-scientific evidence. The new factor acknowledges that infection with SARS-CoV-2 can be a significant contributing factor to cardiomyopathy, thereby facilitating more precise and equitable assessments of claims by the Repatriation Commission and the Military Rehabilitation and Compensation Commission. The Amendment Instrument imposes specific obligations on claimants and the relevant authorities. Claimants must provide evidence of infection with SARS-CoV-2 as part of their claims for medical treatment and compensation related to cardiomyopathy. The Repatriation Commission and the Military Rehabilitation and Compensation Commission are required to assess these claims in light of the new factor, ensuring that their decisions are informed by the most up-to-date medical-scientific evidence. Furthermore, the Veterans' Review Board and the Administrative Appeals Tribunal must review these decisions, taking into account the new criteria outlined in the Amendment Instrument. This ensures that the process of assessing and reviewing claims is transparent, fair, and grounded in current medical understanding. Breach of the obligations and requirements set out in the Amendment Instrument can lead to various consequences. For claimants, failure to provide the necessary evidence of infection with SARS-CoV-2 may result in the denial of their claims. For the authorities, not adhering to the updated criteria can lead to judicial review and potential findings of administrative error. While the Amendment Instrument itself does not specify penalties for breaches, any actions taken against claimants or authorities would be in accordance with the provisions of the VEA and the Military Rehabilitation and Compensation Act 2004. These Acts provide for penalties and legal remedies in cases of non-compliance, ensuring that the legislative framework is effectively upheld. The Amendment Instrument is compatible with human rights and does not derogate from any human rights recognised or declared in the relevant international instruments. It promotes the human rights of veterans, current and former Defence Force members, and their dependents by facilitating the assessment and determination of claims related to cardiomyopathy. This includes the right to social security, the right to an adequate standard of living, and the right to the highest attainable standard of physical and mental health. By ensuring that the qualifying conditions for benefits are reasonable, proportionate, and transparent, the Amendment Instrument supports the exercise of these rights without discrimination, thereby upholding the principles of equality and non-discrimination in the treatment of veterans and Defence Force members.

Legal classification tags

Area of Law
Veterans' Law
Instrument
Amending Act
Concepts
Definitions & Interpretation
Reporting & Disclosure Obligations
Consultation Requirements
Human Rights Law

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.